Methylated SEPTIN9 plasma test for colorectal cancer detection may be applicable to Lynch syndrome

OBJECTIVE: The plasma-based methylated SEPTIN9 (mSEPT9) is a colorectal cancer (CRC) screening test for adults aged 50–75 years who are at average risk for CRC and have refused colonoscopy or faecal-based screening tests. The applicability of mSEPT9 for high-risk persons with Lynch syndrome (LS), th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hitchins, Megan P, Vogelaar, Ingrid P, Brennan, Kevin, Haraldsdottir, Sigurdis, Zhou, Nianmin, Martin, Brock, Alvarez, Rocio, Yuan, Xiaopu, Kim, Sungjin, Guindi, Maha, Hendifar, Andrew E, Kalady, Matthew F, DeVecchio, Jennifer, Church, James M, de la Chapelle, Albert, Hampel, Heather, Pearlman, Rachel, Christensen, Maria, Snyder, Carrie, Lanspa, Stephen J, Haile, Robert W, Lynch, Henry T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Colorectal Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6577308/
https://www.ncbi.nlm.nih.gov/pubmed/31275589
http://dx.doi.org/10.1136/bmjgast-2019-000299

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6577308/
https://www.ncbi.nlm.nih.gov/pubmed/31275589
http://dx.doi.org/10.1136/bmjgast-2019-000299

Ejemplares similares